Detalles de la búsqueda
1.
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.
Blood
; 121(23): 4749-52, 2013 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23603912
2.
Has MRD monitoring superseded other prognostic factors in adult ALL?
Blood
; 120(23): 4470-81, 2012 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23033265
3.
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.
Blood
; 120(9): 1868-76, 2012 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-22442346
4.
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
Blood
; 120(26): 5185-7, 2012 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23024237
5.
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
Leukemia
; 38(6): 1315-1322, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744919
6.
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Biol Blood Marrow Transplant
; 19(11): 1632-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23850653
7.
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.
Mol Med
; 18: 138-45, 2012 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21968789
8.
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.
Blood
; 113(17): 4011-5, 2009 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-19144982
9.
Multidrug resistance-associated protein 4 (MRP4) gene polymorphisms and treatment response in adult acute lymphoblastic leukemia.
Blood
; 114(26): 5400-1; author reply 5401-2, 2009 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-20018925
10.
Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism.
J Immunol Methods
; 306(1-2): 128-36, 2005 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-16181633
11.
Risk-adapted treatment according to minimal residual disease in adult ALL.
Best Pract Res Clin Haematol
; 15(4): 639-52, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12617868
12.
Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health.
Eur J Obstet Gynecol Reprod Biol
; 107(1): 78-80, 2003 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-12593900
13.
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.
J Clin Oncol
; 29(18): 2493-8, 2011 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21576633
14.
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials.
Blood
; 109(3): 910-5, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17023577
15.
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.
Blood
; 107(6): 2271-8, 2006 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16332971
16.
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
Blood
; 107(3): 1116-23, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16195338
17.
Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Eur J Haematol
; 74(4): 353-8, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15777349
18.
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Blood
; 104(8): 2600-2, 2004 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15205268
Resultados
1 -
18
de 18
1
Próxima >
>>